Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Most amoxicillin courses last 5 to 10 days, though the safe duration depends on the infection being treated, ranging from a single high dose for some dental procedures to 4 to 6 weeks or longer for bone, heart valve, or Lyme-related infections under close medical supervision. Taking it longer than prescribed raises the risk of antibiotic resistance, C. difficile diarrhea, yeast infections, and liver or kidney strain, while stopping early can allow the infection to rebound. Dose length is also adjusted for children, pregnancy, and reduced kidney function, and several important details below explain when a longer or shorter course is appropriate and which symptoms mean you should call your prescriber right away.
Because "how long is safe" hinges on what is actually causing your symptoms, clarifying that first is the fastest way to know whether you need antibiotics at all, a different length of treatment, or a reassessment. Take a free, instant, online symptom check to better understand what may be going on and what steps to take next.
Last reviewed for medical accuracy: 09/24/2026
How Long Can You Safely Take Amoxicillin?
Amoxicillin is a widely prescribed antibiotic used to treat bacterial infections such as ear infections, strep throat, pneumonia, urinary tract infections and skin infections. When taken as directed, it’s generally safe and effective. But “how long can you take amoxicillin” depends on the type of infection, its severity, your medical history and your response to therapy. Below, we’ll break down typical treatment durations, factors that influence how long you should stay on amoxicillin, potential risks of improper use and practical tips to stay safe.
These durations effectively eradicate many strains of Streptococcus, Haemophilus and E. coli when taken on schedule.
Always confirm with your doctor or pharmacist before switching to a shorter regimen.
Most guidelines recommend you shouldn’t exceed 14 days of continuous therapy unless expressly directed by an infectious disease specialist.
Less common but serious side effects—requiring immediate medical attention—are:
For non-urgent concerns—like questions about side effects or duration—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Each person and each infection is different. Ask your prescribing doctor if you’re unsure about your treatment length or if your symptoms aren’t improving as expected.
Speak to a doctor about anything that could be life-threatening or serious. Always follow professional medical advice over general guidelines. If you have concerns about your symptoms or treatment, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. When in doubt, your healthcare provider remains your best resource for personalized care.
(References)
* Longo G, Barbi E. Amoxicillin dosage. Pediatrics. 2002 Jul;110(1 Pt 1):195; author reply 195. doi: 10.1542/peds.110.1.195. PMID: 12093975.
* Kenyon S, Taylor DJ, Tarnow-Mordi WO, ORACLE Collaborative Group. ORACLE--antibiotics for preterm prelabour rupture of the membranes: short-term and long-term outcomes. Acta Paediatr Suppl. 2002;91(437):12-5. doi: 10.1111/j.1651-2227.2002.tb00153.x. PMID: 12200889.
* el Moussaoui R, de Borgie CA, van den Broek P, Hustinx WN, Bresser P, van den Berk GE, Poley JW, van den Berg B, Krouwels FH, Bonten MJ, Weenink C, Bossuyt PM, Speelman P, Opmeer BC, Prins JM. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006 Jun 10;332(7554):1355. doi: 10.1136/bmj.332.7554.1355. PMID: 16763247; PMCID: PMC1479094.
* Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016 Jul;151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006. Epub 2016 Apr 19. PMID: 27102658.
* Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, Sturgeon K, Finn A, Rodriguez-Ruiz JP, Malhotra-Kumar S, Powell C, Faust SN, Alcock AE, Hall D, Robinson G, Hawcutt DB, Lyttle MD, Gibb DM, Sharland M, PERUKI, GAPRUKI, and the CAP-IT Trial Group. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. JAMA. 2021 Nov 2;326(17):1713-1724. doi: 10.1001/jama.2021.17843. PMID: 34726708; PMCID: PMC8564579.
* Peng X, Yao JY, Ma YQ, Li GH, Chen HW, Wan Y, Liang DS, Zhang M, Zhi M. Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Study. Clin Gastroenterol Hepatol. 2024 Jun;22(6):1210-1216. doi: 10.1016/j.cgh.2024.01.022. Epub 2024 Feb 1. PMID: 38309492.
* Qiu S, Huang Y, Chen J, Guo Y, Li M, Ding Z, Liang X, Lu H. Vonoprazan-Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial. Helicobacter. 2024 Jul-Aug;29(4):e13118. doi: 10.1111/hel.13118. PMID: 39087868.
* Lin A, Lin Z, Liu Y, Chen S, Shao Y, Qiu F, Xiao Z, Xu Z, Chen L, Chen L, Lin W, Wang Y, Huang Z, Lin Z, Huang X. Ten-day versus 14-day vonoprazan-amoxicillin high-dose dual therapy for Helicobacter pylori eradication in China: A multicenter, open-label, randomized study. J Gastroenterol Hepatol. 2024 Dec;39(12):2645-2653. doi: 10.1111/jgh.16761. Epub 2024 Nov 24. PMID: 39582213.
* Tao L, Qian H, Zhang L, Luo P, Ma S, Yan J, Liu Y, Chen M, Tao Y, Shi J, Zhang G, Ye F. Optimizing Duration and Dosing Frequency of Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial. Helicobacter. 2025 Jul-Aug;30(4):e70062. doi: 10.1111/hel.70062. PMID: 40804704.
* Wu CQ, Zhou X, Li CP, He QL, Chen ZH, Ding SB, Deng L, Chen LL, Jiang K, Dong CK, Hu L, Zhu GB, Zhang CG, Zhang Y, Wu LL, Li W, Mao YH, Zhang H, Ai X, He YQ, Ma Y, He SY. Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for Helicobacter pylori eradication in Sichuan Province, China. World J Gastroenterol. 2025 Dec 21;31(47):114377. doi: 10.3748/wjg.v31.i47.114377. PMID: 41479756; PMCID: PMC12754164.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.